TickerFactsScreenerDevelopers

Tonix Pharmaceuticals Holding Corp. (TNXP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $1.78M2013: $8.20M2014: $38.18M2015: $19.18M2016: $18.94M2017: $25.50M2018: $25.03M2019: $11.25M2020: $77.07M2021: $178.66M2022: $120.23M2023: $24.95M2024: $98.78M2025: $207.64M$207.64M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$207.64M+110.2%
2024$98.78M+295.9%
2023$24.95M-79.2%
2022$120.23M-32.7%
2021$178.66M+131.8%
2020$77.07M+585.1%
2019$11.25M-55.1%
2018$25.03M-1.8%
2017$25.50M+34.6%
2016$18.94M-1.2%
2015$19.18M-49.8%
2014$38.18M+365.5%
2013$8.20M+359.5%
2012$1.78M—